CDC Endorses Newly-Approved GSK Shingles Vaccine

October 31, 2017

The Centers for Disease Control and Prevention’s vaccination policy advisory committee endorsed Shingrix, GlaxoSmithKline’s newly-approved shingles drug.

The advisory committee favored the drug over the older vaccine, Merck’s Zostavax. In an 8-7 vote, it recommended the shot for individuals 50 and older, whereas earlier recommendations had applied to patients 60 and older.

Final approval of the committee’s endorsement will be up to the CDC.

View today's stories